The FDA has approved patches for uses like birth control, smoking cessation, and pain relief
Further research into the mechanisms underlying these relationships holds promise for identifying novel therapeutic targets and interventions aimed at harnessing the therapeutic potential of the gut microbiome in the treatment of metabolic conditions
References: Albericio, F., & Kruger, H
There is no recommendation on the safety of these medications during pregnancy due to lack of evidence
however, in a meta-analysis of cohort studies comparing glargine to NPH, maternal and fetal outcomes were similar (142) and no adverse maternal or fetal effects have been described to date
The lowered absorption rate and increased frequency attributed to oral supplements can cause the overall treatment process to be slower than that of B12 injections